|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/34 | (2015.01) |
| A61L 27/38 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| C12N 5/077 | (2010.01) |
| (11) | Patento numeris | 3402543 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17738878.2 |
| Europos patento paraiškos padavimo data | 2017-01-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/013054 |
| Data | 2017-01-11 |
| (87) | Numeris | WO 2017/123662 |
| Data | 2017-07-20 |
| (30) | Numeris | Data | Šalis |
| 201662277359 P | 2016-01-11 | US |
| (72) |
MARBAN, Eduardo , US
GALLET, Romain , FR
|
| (73) |
Cedars-Sinai Medical Center ,
8700 Beverly Boulevard, Los Angeles, CA 90048,
US
|
| (54) | CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION |
| CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION |